Treatment of age-related macular degeneration: the possibilities and effectiveness
Abstract
Age-related macular degeneration (AMD) is one of the leading cause of low vision and blindness in the elderly population in the world. The disease affects the central area of the retina - the macular area, resulting in a progressive reduction of visual acuity and loss of ability to reading, which significantly decreases the of patients’s quality of life. Modern methods of treatment allow only to stabilize the disease, so the early diagnostic and prevention of advanced stage are very important.
The pathogenesis of AMD, mechanism of progression, diagnostics and treatment are discussed in the article. The drugs for treatment AMD that were registered in Republic of Belarus are reviewed, the regimen of treatment is presented.
About the Author
H. V. Sitnik
ГУО «Белорусская медицинская академия последипломного образования»
Belarus
Belarus
References
1. Еричев В. П., Петров С. Ю., Волжанин А. В. Метаанализ рандомизированных клинических исследований эффективности нейропротекторной терапии сухой формы ВМД с использованием комплекса водорастворимых полипептидных фракций / В. П. Еричев, С. Ю. Петров, А. В. Волжанин // Офтальмология. – 2018. – Т. 15. – № 1. – С. 69–79.
2. Морхат М. В. Аутофлюоресценция сетчатки при влажной форме возрастной макулярной дегенерации / М. В. Морхат, В. И Морхат, Н. К. Королькова // Международный научно-практический журнал «Офтальмология. Восточная Европа». – Спецвыпуск, 13–14 декабря 2013. – С. 217–225.
3. Степень взаимного влияния и характеристики морфофункциональных взаимоотношений между первичной открытоугольной глаукомой и макулодистрофией / Р. В. Авдеев [и др.] Офтальмологические ведомости. – 2014. – Т. VII. – № 1. – С. 19–26.
4. Щадричев Ф. Е. Возрастная макулярная дегенерация / Ф. Е. Щадричев // Современная оптометрия. – 2008. – № 6. – С. 27–34.
5. Epidemiologie der altersbedingten Makuladegeneration / C. Brandl [et al] // Ophthalmologe. – 2016. – Vol. 113. – P. 735–745.
6. Fish Consumption and Age-Related Macular Degeneration Incidence: A Meta-Analysis and Systematic Review of Prospective Cohort Studies / W. Zhu [et al] // Nutrients. – 2016. – Vol. 8. – N 11, 743. doi: 10.3390/nu8110743.
7. Gehlbach P., Tianjing L., Hatef E. Statins for age-related macular degeneration / P. Gehlbach, L. Tianjing, E. Hatef Cochrane Database Syst. Rev. – N 8:CD006927. – doi:10.1002/14651858.CD006927.pub5.
8. Geo-Epidemiology of Age-Related Macular Degeneration: New Clues Into the Pathogenesis / M. Reibaldi [et al] // Am. J. Ophthalmol. – 2016. – Vol. 161. – P. 78-93. e1-2. doi: 10.1016/j.ajo.2015.09.031. Epub 2015 Oct 24.
9. Incidence of Late-Stage Age-Related Macular Degeneration in American Whites: Systematic Review and Metaanalysis / A. Rudnicka [et al] // Am.J. Ophthalmol. – 2015. – Vol. 160. – P. 85-93.
10. Lipids, Lipid Genes and Incident Age-Related Macular Degeneration: The Three Continent Age-Related Macular Degeneration Consortium. /R. Klein [et al] // Am.J. Ophthalmol. – 2014. – Vol. 158. – N 3. – P. 513-524. doi: 10.1016/j.ajo.2014.05.027.
11. Secondary Analyses of the Effects of Lutein/Zeaxanthin on AgeRelated Macular Degeneration Progression AREDS2 Report No 3 / JAMA Ophthalmol. – 2014. – Vol. 132. – N 2. – P. 142–149.
12. Weaver T. R., Beaumont P. E. The effect of intensive education on concordance with the Age-Related Eye Disease Study (AREDS) recommendations in a tertiary referral practice / T. R. Weaver, P. E. Beaumont // Ophthalmologica. – 2015. – Vol. 233. – N 2. – P. 61–5.
Review
For citations:
Sitnik H.V. Treatment of age-related macular degeneration: the possibilities and effectiveness. Military Medicine. 2018;(3):40-44. (In Russ.)
Views:
53
JATS XML
Email this article 